Oxford University Innovation’s Clinical Outcomes manages the provision (licensing) and support of high quality clinical outcome assessments (COA) developed at the University of Oxford and elsewhere. The vast majority of our measures are Patient Reported Outcome (PRO) Measures (or sometimes referred to as PROMs).
We provide licences for some of the most respected and widely deployed outcome measures used by the pharmaceutical industry, healthcare providers, academia and medical device manufacturers.
The Clinical Outcomes team can also provide expert advice on the development and psychometric validation of new COAs and PROs, as well as the use of our own and other health outcome measures.
The generic Patient Reported Outcome (PRO) measure – the Oxford Participation and Activities Questionnaire (OxPAQ) has been further validated for use in three more common conditions.
Minimal Important Difference (MID) and Effect Sizes for the measure’s domains now available
Oxford University Innovation's Clinical Outcome team will be attending the annual PROMS research conference in Leeds, UK on the 13th June 2019.
